SFX by Ex Libris Inc.

Title:	Doxorubicin-loaded nanospheres bypass tumor cell multidrug resistance
Source:	Biochemical Pharmacology [0006-2952] Cuvier, C yr:1992

Basic

Full text

Full text available via Elsevier SD Backfile Pharmacology

Year:

Volume:

Issue:

Start Page:

Full text available via EZB-NALI5-00465 Elsevier Archive NL

Year:

Volume:

Issue:

Start Page:

Document delivery

Request document via Library/Bibliothek

Users interested in this article also expressed an interest in the following:
description	1.	Makhlof, H. "Design and evaluation of novel pH-sensitive chitosan nanoparticles for oral insulin delivery." European journal of pharmaceutical sciences 42.5 (2010): 445-451.
description	2.	DEVERDIERE, A. "UPTAKE OF DOXORUBICIN FROM LOADED NANOPARTICLES IN MULTIDRUG-RESISTANT LEUKEMIC MURINE CELLS." Cancer chemotherapy and pharmacology 33.6 (1994): 504-508.
description	3.	Betancourt, T. "Doxorubicin-loaded PLGA nanoparticles by nanoprecipitation: preparation, characterization and in vitro evaluation." Nanomedicine 2.2 (2007): 219-232.
description	4.	XU, W. "pH-Controlled drug release from mesoporous silica tablets coated with hydroxypropyl methylcellulose phthalate." Materials research bulletin 44.3 (2009): 606-612.
description	5.	Dong, X. "Doxorubicin and paclitaxel-loaded lipid-based nanoparticles overcome multidrug resistance by inhibiting P-glycoprotein and depleting ATP." Cancer research 69.9 (2009): 3918-26.
description	6.	Wang, L. "Layer-by-layer assembled microgel films with high loading capacity: Reversible loading and release of dyes and nanoparticles." Langmuir 24.5 (2008): 1902-1909.
description	7.	Osmers, R. "Origin of cervical collagenase during parturition." American journal of obstetrics and gynecology 166.5 (1992): 1455-60.
description	8.	Yoo, K H S. "Biodegradable nanoparticles containing doxorubicin-PLGA conjugate for sustained release." Pharmaceutical Research 16.7 (1999): 1114-1118.
description	9.	Gan, Q. "Modulation of surface charge, particle size and morphological properties of chitosan-TPP nanoparticles intended for gene delivery." Colloids and surfaces. B, Biointerfaces 44.2 (2005): 65-73.
description	10.	Wolfe, Charles M. "Cell-Free Hemoglobin-Based Blood Substitutes and Risk of Myocardial Infarction and Death: A Meta-analysis." JAMA 299.19 (2008): 2304-12.
description	11.	Lian, T. "Trends and developments in liposome drug delivery systems." Journal of pharmaceutical sciences 90.6 (2001): 667-80.
description	12.	Wattendorf, U. "Stable Stealth Function for Hollow Polyelectrolyte Microcapsules through a Poly(ethylene glycol) Grafted Polyelectrolyte Adlayer." Biomacromolecules 9.1 (2008): 100-108.
description	13.	Barenholz, Y. "Liposome application: problems and prospects." Current opinion in colloid & interface science 6.1 (2001): 66-77.
description	14.	Sharma, A. "Liposomes in drug delivery: progress and limitations." International Journal of Pharmaceutics 154.2 (1997): 123-140.
description	15.	Panyam, J. "Biodegradable nanoparticles for drug and gene delivery to cells and tissue." Advanced drug delivery reviews 55.3 (2003): 329-347.
description	16.	Wattendorf, U. "Phagocytosis of poly(L-lysine)-graft-poly(ethylene glycol) coated microspheres by antigen presenting cells: impact of grafting ratio and poly(ethylene glycol) chain length on cellular recognition." Biointerphases 1.4 (2006): 123-133.
description	17.	Rempf, C. "Administration of bovine polymerized haemoglobin before and during coronary occlusion reduces infarct size in rabbits++." British Journal of Anaesthesia 103.4 (2009): 496-504.
description	18.	BYRNE, J. "Active targeting schemes for nanoparticle systems in cancer therapeutics." Advanced Drug Delivery Reviews 60.15 (2008): 1615-1626.
description	19.	Liscovitch, M. "A case study in misidentification of cancer cell lines: MCF-7/AdrR cells (re-designated NCI/ADR-RES) are derived from OVCAR-8 human ovarian carcinoma cells." Cancer Letters 245.1/2 (2006): 350-2.
description	20.	Kaneda Y, Y. "Virosomes: evolution of the liposome as a targeted drug delivery system." Advanced drug delivery reviews 43.2 (2000): 197-205.